Martijn Fenaux, Ph.D.
Vice President, Biology
Dr. Fenaux is the Vice President of Biology and Co-Founder of Terns, who brings 15 years of experience in drug discovery and development of small molecules and vaccines in both academic and industrial settings. He is the co-inventor of the approved livestock vaccine Fostera® PCV MH. Dr. Fenaux led and contributed to the discovery and development of multiple anti-viral inhibitors at Gilead Sciences and Novartis. Prior to co-founding Terns Pharmaceuticals, he served as a group leader at Novartis Institutes for BioMedical Research where he oversaw the HBV drug discovery program. Prior to Novartis, Dr. Fenaux supported HCV drug discovery efforts at Gilead Sciences.
Dr. Fenaux received his Ph.D. in Virology from Virginia Tech and completed his postdoctoral research at Stanford University.